Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7 (original) (raw)
Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897–907 ArticleCASPubMed Google Scholar
Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PloS One 6:e23937 ArticleCASPubMed CentralPubMed Google Scholar
Chang C-C, Lin C-C, Hsieh W-L, Lai H-W, Tsai C-H, Cheng Y-W (2014) MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis C. Dis Markers 2014:1–9 Article Google Scholar
Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178–191 ArticleCASPubMed Google Scholar
Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laffi G (2013) Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PloS One 8:e62965 ArticleCASPubMed CentralPubMed Google Scholar
Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327:1–23 ArticleCASPubMed Google Scholar
Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930–938 ArticleCASPubMed Google Scholar
Z-z Jiang, G-y Xia, Zhang Y, Dong L, B-z He, J-g Sun (2013) Attenuation of hepatic fibrosis through ultrasound-microbubble-mediated HGF gene transfer in rats. Clin Imaging 37:104–110 Article Google Scholar
Kinoshita T, Tashiro K, Nakamura T (1989) Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 165:1229–1234 ArticleCASPubMed Google Scholar
Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang Z-F, Tabor K, Kim J, Hargrave S, Cuevas KH (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37:727–739 CASPubMed Google Scholar
Liaw YF, Tai DI, Chu CM, Chen TJ (1988) The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8:493–496 ArticleCASPubMed Google Scholar
Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T (1997) Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26:81–89 ArticleCASPubMed Google Scholar
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 105:10513–10518 ArticleCASPubMed CentralPubMed Google Scholar
Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W (1998) Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28:1687–1695 ArticleCASPubMed Google Scholar
Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349:825–832 ArticleCASPubMed Google Scholar
Roderburg C, Luedde M, Cardenas DV, Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C, Weiskirchen R, Frey N (2013) miR-133a mediates TGF-b-dependent de-repression of collagen-synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 58:S245–S246 Article Google Scholar
Shao R-X, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, Shiina S, Taniguchi H, Moriyama M, Kawabe T (2005) Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World J Gastroenterol 11:1995–1999 ArticleCASPubMed CentralPubMed Google Scholar
Sukata T, Sumida K, Kushida M, Ogata K, Miyata K, Yabushita S, Uwagawa S (2011) Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol Lett 200:46–52 ArticleCASPubMed Google Scholar
Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, Wedemeyer I, Drebber U, Rockstroh J, Sauerbruch T (2013) Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol 58:234–239 ArticleCASPubMed Google Scholar
Tsukada S, Parsons CJ, Rippe RA (2006) Mechanisms of liver fibrosis. Clin Chim Acta 364:33–60 ArticleCASPubMed Google Scholar
Verrecchia F, Chu M-L, Mauviel A (2001) Identification of novel TGF-b/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276:17058–17062 ArticleCASPubMed Google Scholar
Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E (2011) Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 105:146–153 ArticleCASPubMed CentralPubMed Google Scholar
Yang Q, Fu S, Wang J (2014) Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758. Arch Virol 159:2997–3003 ArticleCASPubMed Google Scholar
Zarnegar R, DeFrances MC, Kost DP, Lindroos P, Michalopoulos GK (1991) Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 177:559–565 ArticleCASPubMed Google Scholar